10:25 AM EST - Endo International plc : Reported third-quarter 2016 financial results, including: Revenues of $884 million including the addition of sales from its 2015 acquisition of Par Pharmaceutical, a 19% increase compared to third-quarter 2015 revenues of $746 million. Reported net loss from continuing operations of $191 million compared to third-quarter 2015 reported net loss from continuing operations of $804 million. Endo International plc
shares T.ENL are trading down $1.57 at $18.94.
